Stay updated with breaking news from Cell Assist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gamida Cell Ltd. announced that the U.S. Food and Drug Administration has approved Gamida Cell's allogeneic cell therapy, Omisirge® , for use in adult and pediatric patients 12 years and... | April 18, 2023
The US Food and Drug Administration (FDA) has approved Gamida Cell’s allogeneic cell therapy, Omisirge (omidubicel-onlv), for blood cancer patients.
Omisirge is approved by the FDA as a new donor source for allogeneic stem cell transplant Global, randomized Phase 3 clinical trial showed faster neutrophil recovery and reduced bacterial and... | April 17, 2023
GMDA earnings call for the period ending March 31, 2021.